Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment
about
Molecular Imaging of Pancreatic Cancer with Antibodies.High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells.A mutated anti-CA19-9 scFv-Fc for positron emission tomography of human pancreatic cancer xenografts.Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer.Anti-carcinoembryonic antigen single-chain variable fragment antibody variants bind mouse and human neonatal Fc receptor with different affinities that reveal distinct cross-species differences in serum half-lifeIMAC capture of recombinant protein from unclarified mammalian cell feed streamsEngineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancersBiodistribution Analyses of a Near-Infrared, Fluorescently Labeled, Bispecific Monoclonal Antibody Using Optical ImagingCross-species analysis of Fc engineered anti-Lewis-Y human IgG1 variants in human neonatal receptor transgenic mice reveal importance of S254 and Y436 in binding human neonatal Fc receptor.Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors.Selecting Tumor-Specific Molecular Targets in Pancreatic Adenocarcinoma: Paving the Way for Image-Guided Pancreatic Surgery.Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasisGeneration and evaluation of antibody agents for molecular imaging of CD44v6-expressing cancers.Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
P2860
Q30393523-CABECC4B-053A-402E-8EC5-CED8E3B9F220Q34784806-6462E3D8-5F62-4D4E-9580-2900C4B725DCQ35101113-406D1691-2CE0-40CB-B175-738F87A88088Q36067165-EF4DC766-CA84-4C67-A484-3BEEC837787BQ36080399-C51FF670-23FD-433F-818F-8113B2AD8C9EQ36532870-7CD67B19-503C-401B-BFDD-C62EEF30762AQ36699195-C80C5FDA-1557-40D9-B60D-AC97E8718061Q36781729-D8101E95-9A74-43A3-BD90-1C4869714403Q37138959-5E257A8F-FDC0-4C7D-826D-25C26DC3F168Q37174021-A3716487-0B80-4749-8669-64E9D880B09EQ37366754-C840C9D8-B2E3-4176-89A2-903F96A9A9F1Q37389699-0A29404A-A4D6-408D-9ECE-FC0E637A2D19Q37411831-E8849D29-E053-4898-80AC-34C3CD97B883Q42371513-CFDE9682-E0DE-46A1-B5A4-C84A6D5236DEQ47645403-5B11DB74-43D7-41A7-98D9-83BF994C8FA1
P2860
Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment
@ast
Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment
@en
type
label
Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment
@ast
Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment
@en
prefLabel
Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment
@ast
Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment
@en
P2093
P2860
P356
P1433
P1476
Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment
@en
P2093
James S Tomlinson
Katelyn E McCabe
Mark D Girgis
Tove Olafsen
Vania Kenanova
P2860
P2888
P356
10.1186/2191-219X-1-24
P577
2011-11-07T00:00:00Z
P5875
P6179
1047583533